|
|
|||
Osteogenesis imperfecta (OI) is a group of disorders characterized by brittle bones, Dentinogenesis imperfecta and hearing loss. The clinical spectrum of OI ranges from severe forms with perinatal lethality to milder presentations with some bone deformity and short or normal stature. OI manifests genetic heterogeneity with most cases of autosomal dominant OI being attributed to mutations in the type I collagen genes that cause abnormal fibril formation. Autosomal recessive forms of OI were shown to be associated with abnormal function of CASP and Leprecan proteins which are involved in posttranslational modification of collagen fibrils. Cartilage associated protein (CASP), encoded by the CRTAP gene on chromosome 3, forms a complex with Leprecan (P3H1) protein and is required for efficient 3-hydroxylation of fibrillar collagen prolyl residue. Loss of function mutations in the CRTAP gene cause abnormal bone formation and lead to OI . Diagnostic sequencing analysis of the CRTAP gene coding region is now being offered for OI patients and their at-risk relatives on a clinical basis. Reasons for Referral:
Testing Methodology:PCR amplification of seven exons contained in the CRTAP gene coding region is performed on patient genomic DNA. Direct sequencing of amplification products is performed in both forward and reverse directions using automated fluorescence dideoxy sequencing methods using capillary electrophoresis. Sensitivity:Analytical: ~99% Specimen Requirements:Blood for DNA: EDTA
(purple-top) tubes: Adults: 14 cc; Child/Infant: 6 cc Turnaround Time:Index: 4
weeks CPT Codes and Prices: Index: 83891, 83898X8,
83894, 83904x16, 83909x16, 83912 References:1. Morello R, et al. (2006) Cell 127: 291-304 Shipping InformationForms: >> Gene
Sequencing Requisition Test Codes:Index: 6310 |